158 related articles for article (PubMed ID: 9787950)
1. Antiproteinuric efficacy of fosinopril after renal transplantation is determined by the extent of vascular and tubulointerstitial damage.
Lufft V; Kliem V; Hamkens A; Bleck JS; Eisenberger U; Petersen R; Ehlerding G; Maschek H; Pichlmayr R; Brunkhorst R
Clin Transplant; 1998 Oct; 12(5):409-15. PubMed ID: 9787950
[TBL] [Abstract][Full Text] [Related]
2. ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study.
Maschio G; Cagnoli L; Claroni F; Fusaroli M; Rugiu C; Sanna G; Sasdelli M; Zuccalà A; Zucchelli P
Nephrol Dial Transplant; 1994; 9(3):265-9. PubMed ID: 8052432
[TBL] [Abstract][Full Text] [Related]
3. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
Tylicki L; Renke M; Rutkowski P; Rutkowski B; Lysiak-Szydłowska W
Med Sci Monit; 2005 Apr; 11(4):PI31-7. PubMed ID: 15795705
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial: lisinopril reduces proteinuria, ammonia, and renal polypeptide tubular catabolism in patients with chronic allograft nephropathy.
Amara AB; Sharma A; Alexander JL; Alfirevic A; Mohiuddin A; Pirmohamed M; Close GL; Grime S; Maltby P; Shawki H; Heyworth S; Shenkin A; Smith L; Sharma AK; Hammad A; Rustom R
Transplantation; 2010 Jan; 89(1):104-14. PubMed ID: 20061926
[TBL] [Abstract][Full Text] [Related]
5. Reduction of proteinuria during intensified antihypertensive therapy in children after renal transplantation.
Seeman T; Simková E; Kreisinger J; Vondrák K; Dusek J; Dvorák P; Stuchlikova H; Janda J
Transplant Proc; 2007 Dec; 39(10):3150-2. PubMed ID: 18089341
[TBL] [Abstract][Full Text] [Related]
6. Management of moderate to severe hypertension and proteinuria by nifedipine retard and perindopril after renal transplantation.
Grekas D; Dioudis C; Kalevrosoglou I; Papoulidou F; Goutsaridis N; Alivanis P; Tourkantonis A
Clin Nephrol; 1995 Nov; 44(5):299-302. PubMed ID: 8605709
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency.
Tong PC; Ko GT; Chan WB; Ma RC; So WY; Lo MK; Lee KF; Ozaki R; Chow CC; Cockram CS; Chan JC
Diabetes Obes Metab; 2006 May; 8(3):342-7. PubMed ID: 16634995
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
[TBL] [Abstract][Full Text] [Related]
9. Renal allograft protection with early angiotensin-converting enzyme inhibitors administration.
Montanaro D; Gropuzzo M; Tulissi P; Boscutti G; Mioni R; Risaliti A; Baccarani U; Adani GL; Sainz M; Bresadola F; Mioni G
Transplant Proc; 2004 Apr; 36(3):692-4. PubMed ID: 15110633
[TBL] [Abstract][Full Text] [Related]
10. Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.
Catapano F; Chiodini P; De Nicola L; Minutolo R; Zamboli P; Gallo C; Conte G
Am J Kidney Dis; 2008 Sep; 52(3):475-85. PubMed ID: 18468748
[TBL] [Abstract][Full Text] [Related]
11. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
12. Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease.
Sato A; Hayashi K; Saruta T
Am J Hypertens; 2005 Jan; 18(1):44-9. PubMed ID: 15691616
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
Lv J; Zhang H; Chen Y; Li G; Jiang L; Singh AK; Wang H
Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
[TBL] [Abstract][Full Text] [Related]
14. Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria.
Ellis D; Vats A; Moritz ML; Reitz S; Grosso MJ; Janosky JE
J Pediatr; 2003 Jul; 143(1):89-97. PubMed ID: 12915830
[TBL] [Abstract][Full Text] [Related]
15. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy.
Artz MA; Hilbrands LB; Borm G; Assmann KJ; Wetzels JF
Nephrol Dial Transplant; 2004 Nov; 19(11):2852-7. PubMed ID: 15466882
[TBL] [Abstract][Full Text] [Related]
16. Is the antiproteinuric response to inhibition of the renin-angiotensin system less effective during the night?
Buter H; Hemmelder MH; van Paassen P; Navis G; de Zeeuw D; de Jong PE
Nephrol Dial Transplant; 1997; 12 Suppl 2():53-6. PubMed ID: 9269701
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone breakthrough during therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in proteinuric patients with immunoglobulin A nephropathy.
Horita Y; Taura K; Taguchi T; Furusu A; Kohno S
Nephrology (Carlton); 2006 Oct; 11(5):462-6. PubMed ID: 17014562
[TBL] [Abstract][Full Text] [Related]
18. Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis.
Windt WA; Prakash J; Kok RJ; Moolenaar F; Kluppel CA; de Zeeuw D; van Dokkum RP; Henning RH
J Renin Angiotensin Aldosterone Syst; 2004 Dec; 5(4):197-202. PubMed ID: 15803438
[TBL] [Abstract][Full Text] [Related]
19. Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.
Vogt L; de Zeeuw D; Woittiez AJ; Navis G
Nephrol Dial Transplant; 2009 Apr; 24(4):1182-9. PubMed ID: 19037084
[TBL] [Abstract][Full Text] [Related]
20. Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial.
Szeto CC; Chow KM; Kwan BC; Chung KY; Leung CB; Li PK
Am J Kidney Dis; 2008 May; 51(5):724-31. PubMed ID: 18436082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
